Variant report
Variant | esv3398048 |
---|---|
Chromosome Location | chr4:95695719-95696187 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs373089667 | chr4:95695727-95695728 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs141331027 | chr4:95695733-95695734 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs562227330 | chr4:95695745-95695746 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs530894772 | chr4:95695747-95695748 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs189964102 | chr4:95695834-95695835 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs6838436 | chr4:95695904-95695905 | Weak transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs62316513 | chr4:95695909-95695910 | Weak transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs150366631 | chr4:95695912-95695913 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs373323909 | chr4:95695947-95695948 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs546262468 | chr4:95695954-95695955 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs181500661 | chr4:95696000-95696001 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs11344222 | chr4:95696017-95696018 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs376253769 | chr4:95696021-95696022 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs571345083 | chr4:95696076-95696077 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs567053652 | chr4:95696095-95696096 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs4699681 | chr4:95696101-95696102 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs537520091 | chr4:95696116-95696117 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs138098863 | chr4:95696156-95696157 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Cancer | 19907438 | CNVD |
Prostate cancer | 16573809 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:95683000-95703600 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr4:95694600-95696000 | Flanking Active TSS | A549 | lung |
3 | chr4:95696000-95696600 | Enhancers | A549 | lung |